Mannkind reported $-17947000 in Net Income for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Biocryst Pharmaceuticals BCRX:US USD -71541000 29.02M
Dynavax Technologies DVAX:US USD 67.73M 3.92M
Eli Lilly And LLY:US USD 1.94B 486M
Halozyme Therapeutics HALO:US USD 57.7M 3.93M
Immunogen IMGN:US USD -59008000 18.75M
Insmed INSM:US USD -160123000 28.98M
JAZZ PHA JAZZ:US USD -240724000 221.08M
Karyopharm Therapeutics KPTI:US USD -38506000 2.18M
Macrogenics MGNX:US USD 12.8M 37.61M
Mannkind MNKD:US USD -17947000 3.51M
Merk MRK:US USD 3.02B 231M
Minerva Neurosciences NERV:US USD -6726000 175K
Novavax NVAX:US USD -182249000 13.64M
Novo Nordisk A Fs NVO:US DKK 13.59B 813M
Peregrine Pharmaceuticals PPHM:US USD 461K 1.62M
Pfizer PFE:US USD 5B 3.61B
Xencor XNCR:US USD -12042000 20.72M